The clinical phenotypes of MYO3A-associated HL varied among cases in previous reports [17,18,19,20,21,22,23,24,25,26], with some cases showing congenital HL, whereas others showed late-onset HL. This evidence concerns the gene MYO3A and Hodgkins lymphoma.